Pharmacologically induced ischemia-reperfusion syndrome in the rat small intestine

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages 34-41

  Gimenez Crouseilles J ^a   Puig Parellada, P ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

allopurinol; catalase; ischemia reperfusion; L arginine; L NAME; nitric oxide; norepinephrine; rats; reactive oxygen species; SOD

Indexed keywords

ALLOPURINOL; ARGININE; CATALASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; INTESTINE INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE INJURY; VASOSPASM;

ALLOPURINOL; ANIMALS; ARGININE; CATALASE; CONSTRICTION; INTESTINE, SMALL; MALE; MODELS, ANIMAL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 79955598862     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.02.022     Document Type: Article

References (42)

1. Chiu CJ, Scott HJ, Gurd FN. Intestinal mucosal lesion in low flow states. II. The protective effect of intraluminal glucose as energy substrate. Arch Surg 1970;101:484.
2. Gutteridge JMC, Halliwell B. Reoxygenation injury and antioxidant protection: Tale of two paradoxes. Arch Biochem Biophys 1990;283:223.
3. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:22.
4. Parks DA, Grøgaard B, Granger DN. Comparison of partial and complete arterial occlusion models for studying intestinal ischemia. Surgery 1982;92:896.
5. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol 1986;250:G749.
6. Latham F. The oxygen paradox. Experiments on the effects of oxygen in human anoxia. Lancet 1951;1:77.
7. Hearse DJ, Humphrey RM, Chain EB. Abrupt reoxygenation of the anoxic potassium arrested rat heart: A study of myocardial enzyme release. J Mol Cell Cardiol 1973;5:395.
8. Fridovich I. Hypoxia and oxygen toxicity. Adv Neurol 1979;26:255.
9. Haglund U, Bulkley GB, Granger DN. On the pathophysiology of intestinal ischemic injury. Acta Chir Scand 1987;153:321.
10. Bulkley GB, Kvietys PR, Parks DA, et al. Relationship of blood flow and oxygen consumption to ischemic injury in the canine small intestine. Gastroenterology 1985;89:852.
11. McCord JM. Oxygen derived free radicals in postischemic tissue injury. N Eng J Med 1985;312:159.
12. Grisham MB, Granger DN, Lefer DJ. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease. Free Rad Biol Med 1998;25:404.
13. Lefer AM, Lefer DJ. Nitric oxide. II. Nitric oxide protects in intestinal inflammation. Am J Physiol 1999;276:G572.
14. Greenhouse SW, Geisser S. On methods in the analysis of profile data. Psychometrica 1959;24:95.
15. Armitage P, Berry G. Estadística para la investgación biomédica. Barcelona: Ed. DOYMA, 1992:346-416.
16. Riba, MD. Modelo lineal de análisis de la variancia. Barcelona: Ed. Herder, 1990:167.
17. Parks DA, Bulkley GB, Granger DN, et al. Ischemic injury in the cat small intestine: Role of superoxide radicals. Gastroenterology 1982;82:9.
18. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986;251:G567.
19. Granger DN, Benoit JN, Suzuki M, et al. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989;257:G683.
20. Willcox MG, Howard TJ, Plaskon LA, et al. Current theories of pathogenesis and treatment of nonocclusive mesenteric ischemia. Dig Dis Sci 1995;40:709.
21. Williams LF. Vascular insufficiency of the intestines. Gastroenterology 1971;61:757.
22. Udassin R, Vromen A, Haskel Y. The time sequence of injury and recovery following transient reversible intestinal ischemia. J Surg Res 1994;56:221.
23. Garcia Garcia J, Martin Rollan C, Refoyo Enriquez MA, et al. Improved survival in intestinal ischemia by alopurinol not related to xanthine-oxidase inhibition. J Surg Res 1990;48:144.
24. Das DK, Engelman RM, Clement R, et al. Role of xanthine oxidase inhibitor as free radical scavenger: A novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. Biochem Biophys Res Commun 1987;148:314.
25. Moorhouse PC, Grootveld M, Halliwell B, et al. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett 1987;213:23.
26. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: Reoxygenation injury. Pediatrics 1996;98:103.
27. Zimmerman BJ, Parks DA, Grisham MB, et al. Allopurinol does not enhance antioxidant properties of extracellular fluid. Am J Physiol 1988;255:H202.
28. Klein AS, Joh JW, Rangan U, et al. Allopurinol: Discrimination of antioxidant from enzyme inhibitory activities. Free Rad Biol Med 1996;21:713.
29. Millar TM, Stevens CR, Bemjamin N, et al. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998;427:225.
30. Deshmukh DR, Mirochnitchenko O, Ghole VS, et al. Intestinal ischemia and reperfusion injury in transgenic mice overexpressing copper-zinc superoxide dismutase. Am J Physiol 1997;273:C1130.
31. Lum H, Barr DA, Shaffer JR, et al. Reoxygenation of endothelial cells increases permeability by oxidant dependent mechanisms. Circ Res 1992;70:991.
32. Biemond P, Swaak AJG, Beindorff CM, et al. Superoxide-dependent and independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Biochem J 1986;239:169.
33. Huber W, Saifer MGP, Williams LD. Superoxide dismutase pharmacology and orgotein efficacy: New perspectives. In: Bannister WH, Bannister JV, Eds. Developments in Biochemistry. Vol. 11B: Biological and clinical aspects of superoxide and superoxide dismutase. New York: Elsevier North Holland, Inc, 1980:395.
34. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 1996;271:C1424.
35. Hobbs AJ, Fukuto JM, Ignarro LJ. Formation of free nitric oxide from L-arginine by nitric oxide synthase: Direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci USA 1994;91:10992.
36. Ress DD, Palmer RMJ, Schulz R, et al. Br J Pharmacol. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo 1990;101:746.
37. Dignass AU, Podolsky DK, Rachmilewitz D. NOx generation by cultured small intestinal epithelial cells. Dig Dis Sci 1995;40:1859.
38. Kurose I, Kubes P, Wolf R, Anderson DC, et al. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 1993;73:164.
39. Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992;262:G1138.
40. Kubes P. Ischemia reperfusion in feline small intestine: A role for nitric oxide. Am J Physiol 1993;264:G143.
41. Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusion induced intestinal mucosal permeability. Am J Physiol 1993;265:G189.
42. Ward DT, Lawson SA, Gallagher CM, et al. Sustained nitric oxide production via L-arginine administration ameliorates effects of intestinal ischemia-reperfusion. J Surg Res 2000;89:13.